Press Releases

All Releases
Mar 08, 2013
AngioDynamics to Present at Barclays Global Healthcare Conference
ALBANY, N.Y. , March 8, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the Barclays Global Healthcare Conference on Tuesday,
Feb 13, 2013
AngioDynamics to Present at RBC Capital Markets Healthcare Conference
ALBANY, N.Y. , Feb. 13, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the RBC Capital Markets Global Healthcare Conference
Feb 01, 2013
AngioDynamics Completes Acquisition of Microsulis Medical
ALBANY, N.Y. , Feb. 1, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today said it has completed the previously announced acquisition of certain
Jan 15, 2013
AngioDynamics to Host Investor and Analyst Day on January 23, 2013
ALBANY, N.Y. , Jan. 15, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will host an investor and analyst meeting on Wednesday,
Oct 16, 2012
AngioDynamics Completes Acquisition of Vortex Medical
ALBANY, N.Y. , Oct. 16, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that it has completed the acquisition of Vortex Medical Inc.
Oct 08, 2012
AngioDynamics Reports Fiscal 2013 First Quarter Financial Results
Net sales of $83.4 million GAAP net loss of $0.02 per share; Adjusted (Non-GAAP) net income of $0.10 per share, a YOY 25% increase Integration of Navilyst Medical yielding significant cost savings Vortex Medical acquisition to strengthen peripheral vascular portfolio ALBANY, N.Y. , Oct.
Displaying 161 - 180 of 637